HIGHFDA DRUG
Curosurf 240 mg Poractant Alfa Recalled for Sterility Concerns (2026)
Chiesi USA recalled 7,235 Curosurf vials distributed nationwide to hospitals and clinics. The recall cites a lack of assurance of sterility. Healthcare providers should stop using the product immediately and contact Chiesi USA for guidance.
CUROSURF
Lack of